|
[1]
|
Patienten mit ersten Anzeichen nachlassender geistiger Leistungsfähigkeit: Was der Hausarzt nicht vergessen sollte
Erfahrungsheilkunde,
2023
DOI:10.1055/a-1997-7091
|
|
|
|
|
[2]
|
Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review
Neuropsychiatric Disease and Treatment,
2023
DOI:10.2147/NDT.S401231
|
|
|
|
|
[3]
|
A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress
Scientific Reports,
2023
DOI:10.1038/s41598-023-32515-6
|
|
|
|
|
[4]
|
Critical analysis of ginkgo preparations: comparison of approved drugs and dietary supplements marketed in Germany
Naunyn-Schmiedeberg's Archives of Pharmacology,
2023
DOI:10.1007/s00210-023-02602-6
|
|
|
|
|
[5]
|
Combined treatment with
Ginkgo biloba
extract EGb 761 plus acetylcholinesterase inhibitors improved cognitive function and neuropsychiatric symptoms in patients with mild cognitive impairment
Alzheimer's & Dementia: Translational Research & Clinical Interventions,
2022
DOI:10.1002/trc2.12338
|
|
|
|
|
[6]
|
Mental Performance and Sport: Caffeine and Co-consumed Bioactive Ingredients
Sports Medicine,
2022
DOI:10.1007/s40279-022-01796-8
|
|
|
|
|
[7]
|
Mental Performance and Sport: Caffeine and Co-consumed Bioactive Ingredients
Sports Medicine,
2022
DOI:10.1007/s40279-022-01796-8
|
|
|
|
|
[8]
|
Combined treatment with
Ginkgo biloba
extract EGb 761 plus acetylcholinesterase inhibitors improved cognitive function and neuropsychiatric symptoms in patients with mild cognitive impairment
Alzheimer's & Dementia: Translational Research & Clinical Interventions,
2022
DOI:10.1002/trc2.12338
|
|
|
|
|
[9]
|
Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease
IUBMB Life,
2022
DOI:10.1002/iub.2613
|
|
|
|
|
[10]
|
Leichte kognitive Beeinträchtigung (MCI) in der altersmedizinischen Praxis: Patientenorientierung, Diagnostik, Behandlung und Ethik
Zeitschrift für Gerontologie und Geriatrie,
2022
DOI:10.1007/s00391-022-02098-4
|
|
|
|
|
[11]
|
Clinical Guidelines for Cognitive Disorders in Elderly and Older Patients
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova,
2021
DOI:10.17116/jnevro20211211036
|
|
|
|
|
[12]
|
A Single Dose of Ginkgo biloba Extract Induces Gene Expression of Hypothalamic Anorexigenic Effectors in Male Rats
Brain Sciences,
2021
DOI:10.3390/brainsci11121602
|
|
|
|
|
[13]
|
Strategies for the use of
Ginkgo biloba
extract, EGb 761
®
, in the treatment and management of mild cognitive impairment in Asia: Expert consensus
CNS Neuroscience & Therapeutics,
2021
DOI:10.1111/cns.13536
|
|
|
|
|
[14]
|
Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®)
Pharmaceuticals,
2021
DOI:10.3390/ph14040305
|
|
|
|
|
[15]
|
The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease
Frontiers in Pharmacology,
2021
DOI:10.3389/fphar.2021.775034
|
|
|
|
|
[16]
|
Management of mild cognitive impairment (MCI): The need for national and international guidelines
The World Journal of Biological Psychiatry,
2020
DOI:10.1080/15622975.2019.1696473
|
|
|
|
|
[17]
|
Prüfplan für die monozentrische prospektive randomisierte placebokontrollierte doppelblinde Phase-II-Studie zur Exploration protektiver Effekte des Ginkgo-biloba-Spezialextrakts EGb 761® vor einer vorübergehenden Hörschädigung durch Lärm
HNO,
2020
DOI:10.1007/s00106-019-00807-x
|
|
|
|
|
[18]
|
Pathology, Prevention and Therapeutics of Neurodegenerative Disease
2019
DOI:10.1007/978-981-13-0944-1_24
|
|
|
|
|
[19]
|
Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba
extract, EGb 761®
CNS Neuroscience & Therapeutics,
2019
DOI:10.1111/cns.13095
|
|
|
|
|
[20]
|
Phytochemicals for Improving Aspects of Cognitive Function and Psychological State Potentially Relevant to Sports Performance
Sports Medicine,
2019
DOI:10.1007/s40279-018-1007-0
|
|
|
|
|
[21]
|
Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence
Oxidative Medicine and Cellular Longevity,
2019
DOI:10.1155/2019/9695412
|
|
|
|
|
[22]
|
Přehled systematických souhrnů studií: využití extraktu z Ginkgo biloba v léčbě mírného kognitivního poškození a demence
Neurologie pro praxi,
2018
DOI:10.36290/neu.2018.145
|
|
|
|
|
[23]
|
Přehled systematických souhrnů studií: využití extraktu z Ginkgo biloba v léčbě mírného kognitivního poškození a demence
Neurologie pro praxi,
2018
DOI:10.36290/neu.2018.145
|
|
|
|
|
[24]
|
Therapeutic efficacy of the Ginkgo special extract EGb761® within the framework of the mitochondrial cascade hypothesis of Alzheimer’s disease
The World Journal of Biological Psychiatry,
2017
DOI:10.1080/15622975.2017.1308552
|
|
|
|
|
[25]
|
A retrospective classification of diagnoses in terms of DSM-5 for patients included in randomized controlled trials of Ginkgo biloba extract EGb 761®
European Archives of Psychiatry and Clinical Neuroscience,
2016
DOI:10.1007/s00406-015-0632-y
|
|
|
|
|
[26]
|
Effects of Ginkgo biloba extract EGb 761® on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective memory impairment - a randomized double-blind placebo-controlled trial
Human Psychopharmacology: Clinical and Experimental,
2016
DOI:10.1002/hup.2534
|
|
|
|
|
[27]
|
An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia
Frontiers in Aging Neuroscience,
2016
DOI:10.3389/fnagi.2016.00276
|
|
|
|
|
[28]
|
Studies in Natural Products Chemistry,
2016
DOI:10.1016/B978-0-444-63932-5.00005-X
|
|
|
|
|
[29]
|
Analysing time to event data in dementia prevention trials: The example of the guidage study of EGB761®
The journal of nutrition, health & aging,
2015
DOI:10.1007/s12603-015-0582-0
|
|
|
|
|
[30]
|
Analysing time to event data in dementia prevention trials: The example of the guidage study of EGB761®
The journal of nutrition, health & aging,
2015
DOI:10.1007/s12603-015-0661-2
|
|
|
|
|
[31]
|
Diet and Nutrition in Dementia and Cognitive Decline
2015
DOI:10.1016/B978-0-12-407824-6.00095-1
|
|
|
|
|
[32]
|
Efficacy and safety ofGinkgo bilobaextract EGb 761®in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial
International Journal of Geriatric Psychiatry,
2014
DOI:10.1002/gps.4103
|
|
|
|
|
[33]
|
Evidence and Rational Based Research on Chinese Drugs
2013
DOI:10.1007/978-3-7091-0442-2_11
|
|
|
|
|
[34]
|
Evidence and Rational Based Research on Chinese Drugs
2013
DOI:10.1007/978-3-7091-0442-2_11
|
|
|
|
|
[35]
|
Clinical data in early intervention
International Psychogeriatrics,
2012
DOI:10.1017/S1041610212000555
|
|
|
|
|
[36]
|
Ginkgo biloba leaf extract (EGb 761®) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761®
International Psychogeriatrics,
2012
DOI:10.1017/S1041610212000567
|
|
|
|